12-hydroxyamino-12-oxododecanoic acid | 62424-66-2

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 12-hydroxyamino-12-oxododecanoic acid
• 英文别名: 11-(hydroxycarbamoyl)undecanoic acid；12-(Hydroxyamino)-12-oxododecanoic acid
• CAS: 62424-66-2
• 化学式: C₁₂H₂₃NO₄
• 分子量: 245.319
• InChiKey: SYXCACKKFONCRD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  86.6
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  在 水 、 lithium hydroxide 作用下， 以 异丙醇 为溶剂， 反应 20.0h， 以38%的产率得到12-hydroxyamino-12-oxododecanoic acid
  参考文献：
  名称：

  新型配体双功能异羟肟酸的合成以稳定氧化铁纳米粒子。

  摘要：

  报道了合成包含羧酸或氨基官能团的双官能异羟肟酸的一般方法。描述了从简单烷基到复杂树状大分子结构的各种产物。此类分子最近已用于配体交换反应中，以对最初由油酸保护的氧化铁纳米粒子进行亲水性稳定作用。 保护基-异羟肟酸-氢化-醚-烷基化

  DOI：

  10.1055/s-0029-1218654

文献信息

• Functionalised Nanoparticles, Their Production and Use
  申请人：Baldi Giovanni

  公开号：US20090054555A1

  公开（公告）日：2009-02-26

  Stable complexes are described, formed by mono- and di-functional compounds bound to nanoparticles composed of various types of transition metal oxides and of metals useful in the production processes of different types of new materials (such as for example some types of hydrophile plastics, fibres); processes for the production of the complexes are also described.

  本文描述了由单功能和双功能化合物与由各种过渡金属氧化物和在生产不同类型新材料（例如某些亲水塑料，纤维）的过程中有用的金属组成的纳米粒子形成的稳定复合物；同时还描述了制备这些复合物的过程。
• FUNCTIONALISED NANOPARTICLES, THEIR PRODUCTION AND USE
  申请人：Colorobbia Italia S.p.a.

  公开号：EP1979365B1

  公开（公告）日：2012-07-11
• MAGNETIC NANOPARTICLES FOR THE APPLICATION IN HYPERTHERMIA, PREPARATION THEREOF AND USE IN CONSTRUCTS HAVING A PHARMACOLOGICAL APPLICATION
  申请人：Colorobbia Italia S.p.a.

  公开号：EP2117600B1

  公开（公告）日：2012-12-05
• DRUG DELIVERY FROM IMPLANTS USING SELF-ASSEMBLED MONOLAYERS-THERAPEUTIC SAMS
  申请人：Agrawal C. Mauli

  公开号：US20090123516A1

  公开（公告）日：2009-05-14

  Disclosed are medical devices comprising one or more surfaces, one or more SAM molecules attached to the one or more surfaces of the medical device, and one or more therapeutic agents attached to the one or more self-assembled monolayer molecules. Also disclosed are medical devices comprising one or more surfaces, one or more self-assembled monolayer molecules attached to the one or more surfaces of the medical device, one or more linkers comprising a first functional group and a second functional group, the first functional group attached to the self-assembled monolayer molecule and a therapeutic agent attached to the second functional group. The therapeutic agent may be attached to the SAM molecule via a linker. The present invention also concerns methods of administering a therapeutic agent to a subject, comprising contacting the subject with one of the medical devices set forth herein.
• US8816107B2
  申请人：——

  公开号：US8816107B2

  公开（公告）日：2014-08-26